The Journal of Organic Chemistry
Note
J = 2.0 Hz, 2H), 3.64 (s, 2H), 3.41 (s, 3H), 2.52 (t, J = 2.0 Hz, 1H);
13C{1H} NMR (126 MHz, CDCl3) δ = 171.3, 161.4 (d, J = 246 Hz),
Rotaxane 13. To a dry flask were added 11 (10 mg, 6.9 μmol, 1.0
equiv) and 12 (5.0 mg, 20.7 μmol, 3.0 equiv). DCM (0.8 mL) and
MeCN (0.2 mL) were added. The solution was degassed four times
by freeze−thaw cycles. The mixture was then cannulated to a
degassed vial containing Cu(MeCN)4PF6 (5.1 mg, 13.8 μmol, 2.0
equiv). The resulting solution was stirred at room temperature
overnight. The crude product was purified by flash column
chromatography (4% MeOH in DCM) yielding 13 as a white solid
(9.8 mg, 74% yield). 1H NMR (500 MHz, CDCl3) δ = 7.87 (bs, 2H),
6.98 (dd, J = 8.5, 8.5 Hz, 8H), 6.89−6.82 (m, 24H), 5.16 (s, 4H),
4.70 (t, J = 5.5 Hz, 4H), 4.57 (t, J = 5.5 Hz, 4H), 4.10 (t, J = 3.5 Hz,
8H), 3.93 (t, J = 4.5 Hz, 4H), 3.79 (t, J = 3.5 Hz, 8H), 3.64 (s, 8H),
3.50 (t, J = 4.0 Hz, 4H), 3.19 (s, 4H); 13C{1H} NMR (126 MHz,
CDCl3) δ = 171.2, 170.2, 161.3 (d, J = 246 Hz), 156.9, 147.6, 144.2,
142.0 (d, J = 3.4 Hz), 138.4, 130.6 (d, J = 7.8 Hz), 130.0, 124.3,
122.2, 114.8 (d, J = 21.0 Hz), 114.3, 113.0, 70.9, 70.5, 68.2, 64.0, 61.9,
59.8, 55.6, 54.1, 50.0, 47.5, 45.6, 30.7; 19F NMR (470 MHz, CDCl3) δ
= −72.63 (d, J = 712 Hz), −116.32; MS-ESI(+) 1774.5 (100, [M −
PF6]+); HRMS (ESI-FTMS) m/z [M − PF6]+ calcd for
C88H96N7O18Br2F41772.5109, found 1772.5047 (for isotopic distri-
Synthesis of Rotaxane 14. Methyl acrylate was filtered through
basic alumina to remove the inhibitor prior to use. A stock solution of
Me6TREN (16 μL, 0.060 mmol) and CuBr2 (5.6 mg, 0.025 mmol) in
dry DMSO (1 mL) was prepared. To a 5 mL vial were added rotaxane
13 (10 mg, 5.2 μmol, 1.0 equiv), 42 μL of catalytic solution
(Me6TREN: 3.0 μmol, 0.48 equiv; CuBr2: 1.2 μmol, 0.2 equiv),
methyl acrylate (0.48 mL, 5.219 mmol, 1000.0 equiv), and dry DMSO
(0.4 mL). This solution was degassed by bubbling with N2 for 10 min.
A Cu(0) wire (∼2 cm, ∼20 mg, 0.315 mmol, ∼100.0 equiv, cleaned in
HClconc for 10 min) wrapped around a stirrer bar was added, and the
solution was degassed for a further 2 min before being allowed to stir
for 2 h. The solution was then precipitated out in stirring methanol,
recovered, and dried under a high vacuum for several days to yield a
white polymer (230 mg, Mn = 45 kDa, Đ = 1.16). Molecular weight
and polydispersity indices were recorded using an analytical GPC that
had been calibrated with polystyrene standards.
156.2, 142.4 (d, J = 3.4 Hz), 139.5, 130.8 (d, J = 7.9 Hz), 130.1, 114.8
(d, J = 21.1 Hz), 114.3, 78.7 (d, J = 2.1 Hz), 75.7 (d, J = 8.1 Hz),
55.9, 54.3, 51.7 (d, J = 2.1 Hz), 46.6; 19F NMR (470 MHz, CDCl3) δ
= −116.59; MS-ESI(+) m/z = 429.2 (100, [M + Na]+), 430.2 (20,
[M + Na]+); HRMS (ESI-FTMS) m/z [M + Na]+ calcd for
C25H20O3F2Na 429.1273, found 429.1262.
3,3-Bis(4-fluorophenyl)-3-(4-(prop-2-yn-1-yloxy)phenyl)-
propanoic Acid 7. To a solution of 6 (812 mg, 2.0 mmol, 1.0 equiv)
in MeOH (2 mL) was added a solution of LiOH (384 mg, 8.0 mmol,
4.0 equiv) in H2O (2 mL). The resulting solution was stirred at room
temperature overnight. The solvent was removed and acidified using 1
M HCl until pH = 2. The crude product was extracted by DCM (3 ×
5 mL) and concentrated. The crude product was used directly
without further purification: mp 95.2−97.0 °C; 1H NMR (500 MHz,
CDCl3) δ = 7.12 (dd, J = 8.5, 9.0 Hz, 4H), 7.07 (d, J = 8.5 Hz, 2H),
6.94 (dd, J = 8.5, 8.5 Hz, 4H), 6.87 (d, J = 9.0 Hz, 2H), 4.66 (d, J =
2.5 Hz, 2H), 3.63 (s, 2H), 2.52 (t, J = 2.5 Hz, 1H); 13C{1H} NMR
(126 MHz, CDCl3) δ = 176.0, 161.3 (d, J = 246 Hz), 156.2, 142.1 (d,
J = 3.4 Hz), 139.3, 130.7 (d, J = 7.8 Hz), 130.1, 114.9 (d, J = 21.2
Hz), 114.4, 78.6 (d, J = 2.0 Hz), 75.8 (d, J = 8.1 Hz), 55.9, 54.0, 46.4;
19F NMR (470 MHz, CDCl3) δ = −116.59.
3,3-Bis(4-fluorophenyl)-3-(4-(prop-2-yn-1-yloxy)phenyl)-
propanoyl Chloride 8. To a solution of 7 (588 mg, 1.5 mmol, 1.0
equiv) in DCM (3 mL) was added 2 drops of DMF. (COCl)2 (0.26
mL, 3 mmol, 2.0 equiv) was added dropwise. The resulting solution
was stirred at room temperature for 2 h. The solvent was removed and
dried under high vacuum. The crude product was used directly
without further purification
Free Thread 10. To a dry flask were added diethanolamine 9 (50
mg, 79 μmol, 1.0 equiv) and AgOTf (45 mg, 158 μmol, 2.2 equiv).
DCM (500 μL) was then added. The solution was cooled in an ice
bath before the addition of 8 (18 mg, 79 μmol, 1.2 equiv). The
resulting solution was stirred at room temperature overnight. The
crude product was purified by flash column chromatography (4%
MeOH in DCM) yielding 10 as a white solid (15 mg, 19% yield): 1H
NMR (500 MHz, CDCl3) δ = 7.76 (bs, 2H), 7.14 (dd, J = 8.5, 8.5 Hz,
8H), 7.07 (d, J = 9.0 Hz, 4H), 6.92 (dd, J = 8.5, 8.5 Hz, 8H), 6.84 (d,
J = 9.0 Hz, 4H), 4.63 (d, J = 2.0 Hz, 4H), 3.99 (t, J = 5.0 Hz, 4H),
3.70 (s, 4H), 2.92 (t, J = 5.5 Hz, 4H), 2.50 (t, J = 2.5 Hz, 2H);
13C{1H} NMR (126 MHz, CDCl3) δ = 171.1, 161.4 (d, J = 246 Hz),
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge at
■
sı
1H, 13C, 19F NMR spectra and rotaxanes isotopic
156.2, 147.61, 141.1 (d, J = 3.3 Hz), 138.9, 130.7 (d, J = 7.6 Hz),
130.2, 114.9 (d, J = 21.3 Hz), 114.4, 78.6 (d, J = 2.1 Hz), 75.9 (d, J =
9.1 Hz), 59.0, 55.9, 54.3, 47.3, 46.1; 19F NMR (470 MHz, CDCl3) δ =
−78.28, −116.04; MS-ESI(+) 854.5 (100, [M − OTf]+), 855.5 (30,
[M − OTf]+); HRMS (ESI-FTMS) m/z [M − OTf]+ calcd for
C52H44NO6F4 854.3099, found 854.3086.
AUTHOR INFORMATION
Corresponding Author
■
Rotaxane 11. To a dry flask were added diethanolamine 9 (50 mg,
79 μmol, 1.0 equiv), dibenzo-24-crown-8(51 mg, 118 μmol, 2.0
equiv), and AgOTf (45 mg, 158 μmol, 2.2 equiv). DCM (100 μL)
was then added. The solution was stirred at room temperature for 2 h.
The solution was cooled in an ice bath before the addition of 8 (18
mg, 79 μmol, 1.2 equiv). The resulting solution was stirred at room
temperature overnight. The crude product was purified by flash
column chromatography (4% MeOH in DCM) yielding 11 as a white
solid (48 mg, 42% yield): 1H NMR (500 MHz, CDCl3) δ = 6.98 (dd,
J = 8.5, 9.0 Hz, 8H), 6.91 (d, J = 8.5 Hz, 4H), 6.89−6.84 (m, 16H),
6.81 (d, J = 9.0 Hz, 4H), 4.64 (d, J = 2.4 Hz, 4H), 4.11 (t, J = 3.5 Hz,
8H), 3.95 (t, J = 4.5 Hz, 4H), 3.81 (t, J = 3.5 Hz, 8H), 3.67 (s, 8H),
3.52 (t, J = 4.0 Hz, 4H), 3.22 (s, 4H), 2.54 (t, J = 2.5 Hz, 2H);
13C{1H} NMR (126 MHz, CDCl3) δ = 170.2, 161.3 (d, J = 246 Hz),
156.1, 147.6, 142.0 (d, J = 3.3 Hz), 139.0, 130.6 (d, J = 7.6 Hz),
130.0, 122.1, 114.8 (d, J = 21.0 Hz), 114.3, 113.0, 78.7 (d, J = 2.6
Hz), 75.9 (d, J = 10.3 Hz), 71.0, 70.5, 68.3, 59.8, 55.9, 54.0, 47.4,
45.5; 19F NMR (470 MHz, CDCl3) δ = −78.10, −116.32; MS-ESI(+)
1302.9 (100, [M − OTf]+), 1304.9 (20, [M − OTf]+); HRMS (ESI-
FTMS) m/z [M − OTf]+ calcd for C76H76NO14F41302.5196, found
1302.5155 (for isotopic distribution, see the SI).
Guillaume De Bo − Department of Chemistry, University of
Manchester, Manchester M13 9PL, United Kingdom;
Authors
Min Zhang − Department of Chemistry, University of
Manchester, Manchester M13 9PL, United Kingdom
Olga Shvetsova − Department of Chemistry, University of
Manchester, Manchester M13 9PL, United Kingdom
Complete contact information is available at:
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
We thank the Royal Society for a Newton International
Fellowship to M.Z., a summer studentship to O.S. (funded
■
D
J. Org. Chem. XXXX, XXX, XXX−XXX